Found 19 matching trials
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC PHASE3 Triple-negative breast cancer (TNBC) presents significant challenges due to...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy PHASE2 The primary aim is to evaluate the efficacy of neoadjuvant SBRT combined wi...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma PHASE2 This is a single-arm, multicenter, prospective, open-label phase II clinica...
Show More Location
Fifth Affilliated Hospital of Sun Yat-sen University
Learn More & Join Trial
SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy PHASE2 SABRE STUDY will explore effectiveness and safety of the combination therap...
Show More Location
Zhongnan Hospital of Wuhan University
Learn More & Join Trial
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC PHASE2 This is a prospective, single-center, single-arm, phase II clinical study. ...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer NA Biliary tract cancer (BTC), including cholangiocarcinoma and gallbladder ca...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. PHASE1 The purpose of this study is to evaluate if the combination of nivolumab an...
Show More Location
Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis PHASE2 Non-small cell lung cancer (NSCLC), the most prevalent form of lung cancer,...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer PHASE2 This phase II study aims to evaluate the efficacy and safety of low-dose ra...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial